Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,090 | 25,789 | 37,574 | 27,691 | 50,211 |
| Marketable Securities | 49,154 | 95,058 | 88,773 | 92,623 | 97,389 |
| Receivables | 7,047 | 2,810 | 402 | N/A | N/A |
| Inventories | 1,964 | 1,346 | 1,125 | N/A | N/A |
| TOTAL | $115,619 | $129,338 | $129,943 | $121,866 | $148,634 |
| Non-Current Assets | |||||
| PPE Net | 2,046 | 1,725 | 1,401 | 991 | 977 |
| Investments And Advances | 1,893 | 5,900 | 26,499 | 40,137 | 48,555 |
| Other Non-Current Assets | 2,447 | 2,930 | 3,234 | 3,935 | 4,222 |
| TOTAL | $6,386 | $10,555 | $31,134 | $45,063 | $53,754 |
| Total Assets | $122,005 | $139,893 | $161,077 | $166,929 | $202,388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,023 | 8,492 | 9,203 | 8,500 | 11,186 |
| Accrued Expenses | 9,554 | 7,791 | 5,744 | 4,075 | 6,711 |
| Other current liabilities | 1,859 | 1,335 | 1,476 | 1,632 | 1,585 |
| TOTAL | $21,436 | $17,618 | $16,423 | $14,207 | $19,482 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,214 | 1,748 | 1,994 | 2,268 | 2,604 |
| TOTAL | $4,214 | $1,748 | $1,994 | $2,268 | $2,604 |
| Total Liabilities | $25,650 | $19,366 | $18,417 | $16,475 | $22,086 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,273 | 22,093 | 22,024 | 21,935 | 21,155 |
| Common Shares | 60 | 60 | 60 | 58 | 57 |
| Retained earnings | -356,501 | -325,975 | -297,159 | -265,810 | -228,017 |
| Other shareholders' equity | 271 | 492 | 760 | 311 | 276 |
| TOTAL | $96,355 | $120,527 | $142,660 | $150,454 | $180,302 |
| Total Liabilities And Equity | $122,005 | $139,893 | $161,077 | $166,929 | $202,388 |